Annals of Clinical Cardiology

REVIEW ARTICLE
Year
: 2020  |  Volume : 2  |  Issue : 1  |  Page : 5--7

Chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease


Deepthi Nair 
 Department of Microbiology, Al-Amiri Hospital, Kuwait City, Kuwait

Correspondence Address:
Dr. Deepthi Nair
Department of Microbiology, Al-Amiri Hospital, Kuwait City
Kuwait

COVID-19 is a zoonotic viral infection caused by severe acute respiratory syndrome coronavirus-2. Although the management of COVID-19 infection is mainly supportive, the arena of infective therapy now also includes drugs such as chloroquine and its substitute, hydroxychloroquine, which are believed to have antiviral properties in addition to their antimalarial and immunomodulating effects. The objective of this review article is to focus on the antiviral effect of chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease.


How to cite this article:
Nair D. Chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease.Ann Clin Cardiol 2020;2:5-7


How to cite this URL:
Nair D. Chloroquine/hydroxychloroquine in the treatment and prophylaxis of COVID-19 disease. Ann Clin Cardiol [serial online] 2020 [cited 2022 May 28 ];2:5-7
Available from: http://www.onlineacc.org/article.asp?issn=2666-6979;year=2020;volume=2;issue=1;spage=5;epage=7;aulast=Nair;type=0